(NaturalNews) The scope of the EpiPen pricing scandal continues to widen, with new questions arising regarding antitrust violations, Medicaid fraud and collusion with state education boards.EpiPen is an epinephrine injection device that has been marketed by drug company Mylan... |
The EpiPen pricing scandal continues, as questions arise regarding possible Medicaid fraud
Continue Reading
Bagikan Berita Ini
0 Response to "The EpiPen pricing scandal continues, as questions arise regarding possible Medicaid fraud"
Post a Comment